Suppr超能文献

环氧化酶1、2和3与前列环素I2的生成:研究对乙酰氨基酚和环氧化酶-2选择性抑制剂在大鼠组织中的活性

Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues.

作者信息

Warner Timothy D, Vojnovic Ivana, Giuliano Francesco, Jiménez Rosario, Bishop-Bailey David, Mitchell Jane A

机构信息

William Harvey Research Institute, Barts and the London, Queen Mary's School of Medicine and Dentistry, University of London, London, United Kingdom.

出版信息

J Pharmacol Exp Ther. 2004 Aug;310(2):642-7. doi: 10.1124/jpet.103.063875. Epub 2004 May 17.

Abstract

It has been suggested recently that cyclooxygenase-3, formed as a splice variant of cyclooxygenase-1, is the enzymatic target for acetaminophen. To investigate the relative roles of the putative three cyclooxygenase isoforms in different target tissues, we compared the inhibitory effects of acetaminophen, a cyclooxygenase-2-selective inhibitor; rofecoxib, a nonsteroid anti-inflammatory drug; naproxen; and a cyclooxygenase-1-selective inhibitor, SC560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole]. Prostanoid production by aorta, heart, lung, and whole blood was inhibited by all drugs tested with the order of potency SC560 > naproxen > acetaminophen >/= rofecoxib. In brain and cerebellum, no differences among drug potencies were found. Reverse transcription-polymerase chain reaction analysis of aorta, brain, cerebellum, heart, and lung showed general expression of cyclooxygenase-1 and cyclooxygenase-3 mRNA and particular expression of cyclooxygenase-2 mRNA in brain and cerebellum. Western blotting demonstrated general expression of cyclooxygenase-1 in test tissues and cyclooxygenase-2 within the brain and cerebellum. Western blotting using a commercially available antibody raised against canine cyclooxygenase-3 failed to detect any immunoreactive proteins. In conclusion, our studies indicate that cyclooxygenase-1 and cyclooxygenase-2 are the functional forms of the enzyme present in the rat tissues tested and that acetaminophen is not a selective inhibitor of "cyclooxygenase" activities in the central nervous system. This is consistent with the apparent impossibility for the expression of cyclooxygenase active protein from cyclooxygenase-3 mRNA in the rat. Also, our experiments show that the ability of rofecoxib to depress the circulating levels of prostaglandin I(2) is more readily associated with its ability to reduce production from the lung, heart, or brain than from arterial vessels.

摘要

最近有人提出,环氧化酶 -3 作为环氧化酶 -1 的剪接变体形式,是对乙酰氨基酚的酶作用靶点。为了研究假定的三种环氧化酶同工型在不同靶组织中的相对作用,我们比较了对乙酰氨基酚、一种环氧化酶 -2 选择性抑制剂;罗非昔布、一种非甾体抗炎药;萘普生;以及一种环氧化酶 -1 选择性抑制剂 SC560 [5-(4 - 氯苯基)-1-(4 - 甲氧基苯基)-3 - 三氟甲基吡唑] 的抑制作用。所有受试药物均抑制主动脉、心脏、肺和全血中前列腺素的生成,其效力顺序为 SC560 > 萘普生 > 对乙酰氨基酚 >= 罗非昔布。在脑和小脑中,未发现药物效力之间存在差异。对主动脉、脑、小脑、心脏和肺进行的逆转录 - 聚合酶链反应分析显示,环氧化酶 -1 和环氧化酶 -3 mRNA 普遍表达,而环氧化酶 -2 mRNA 在脑和小脑中特异性表达。蛋白质印迹法显示环氧化酶 -1 在受试组织中普遍表达,而环氧化酶 -2 在脑和小脑中表达。使用针对犬环氧化酶 -3 制备的市售抗体进行蛋白质印迹法未能检测到任何免疫反应性蛋白。总之,我们的研究表明,环氧化酶 -1 和环氧化酶 -2 是受试大鼠组织中存在的该酶的功能形式,并且对乙酰氨基酚不是中枢神经系统中“环氧化酶”活性的选择性抑制剂。这与大鼠中环氧化酶 -3 mRNA 明显无法表达环氧化酶活性蛋白一致。此外,我们的实验表明,罗非昔布降低循环中前列腺素 I(2) 水平的能力与其降低肺、心脏或脑而非动脉血管中前列腺素生成的能力更密切相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验